Patent · US Active

Injectable alloplastic implants and methods of use thereof

US9370603B2 · kind B2 · utility

0Cited by
10References
23Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 13, 2015
Grant dateJun 21, 2016
Priority date
Expiry dateMar 13, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2430/34
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Described herein are injectable alloplastic implant compositions that are particularly useful for soft tissue defect augmentation. The compositions include microparticles, such as polymethylmethacrylate particles, and collagen as a suspending agent, wherein the collagen contains a reduced amount of low molecular weight gelatine compared to high molecular weight collagen. By controlling the molecular weight of the collagen in the compositions, the injectability, stability, and antigenicity of the alloplastic implant compositions can be improved.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.